ImmuCell ($ICCC) Insider Trading & Smart Money Activity

ImmuCell Corporation · Biotechnology · Latest filing Jun 18, 2026

ImmuCell Corporation ($ICCC) has 2 insider trades on file. In the last 12 months on the open market, 1 insider bought ($152K) and no insider sold, net +$152K.

Insider buyers (12 mo)
1
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$152K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

ICCC insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 2 · $152K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ICCC insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Te Boekhorst Paul Francis OlivierPresident and CEO Buy (Open-market buy) 8K sh $76K +4.2%+17.5% Read
Insider Te Boekhorst Paul Francis OlivierPresident and CEO Buy (Open-market buy) 8K sh $76K +4.2%+17.5% Read

1W / 1M / 6M = how ICCC moved from the trade or filing date.

Insider trading in ICCC: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Te Boekhorst Paul Francis Olivier President and CEO 2 +$152K Jun 18, 2026

Frequently asked questions

Are ICCC insiders buying or selling?

Over the last 12 months 1 insider made 2 open-market purchases worth $152K and 0 insiders made 0 open-market sales worth $0, a net +$152K.

What is the latest insider trade in ICCC?

Te Boekhorst Paul Francis Olivier, President and CEO filed a buy (open-market buy) of 8K sh worth $76K on Jun 18, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text